Sale!

TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test is a specialized diagnostic tool designed to identify mutations in the TBC1D24 gene, which are linked to Autosomal Dominant Nonsyndromic Deafness 65 (DFNA65). This condition is characterized by progressive hearing loss that typically begins in childhood or early adulthood. The test aims to provide individuals and families with crucial genetic information that can aid in understanding their risk of developing this type of hearing impairment, as well as guide potential treatment and management strategies.

Conducted at DNA Labs UAE, a leading facility in genetic testing and personalized medicine, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed using advanced genomic technologies to detect any alterations or mutations in the TBC1D24 gene that are known to cause DFNA65.

The cost of the TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full testing procedure, analysis, and a comprehensive report that explains the results in detail. Patients are encouraged to discuss their results with a genetic counselor or a healthcare provider who can interpret the findings in the context of their personal and family medical history, and provide guidance on next steps.

This genetic test is particularly important for individuals with a family history of hearing loss, as it can provide valuable insights into the genetic basis of their condition and inform decisions about genetic counseling for family planning. It also contributes to the broader understanding of genetic deafness, paving the way for potential advancements in treatment and prevention strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test

Welcome to DNA Labs UAE, where we offer comprehensive genetic testing services. Today, we will be discussing the TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test.

Test Details

The TBC1D24 gene is associated with a form of deafness known as autosomal dominant type 65 (DFNA65). This condition is inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the condition on to each of their children.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. In the context of DFNA65, an NGS genetic test would involve sequencing the TBC1D24 gene to identify any genetic variants or mutations that may be responsible for the condition.

By identifying the specific genetic cause of DFNA65, NGS testing can help with accurate diagnosis, provide information on the inheritance pattern, and guide appropriate management and treatment options. It can also be useful for genetic counseling and family planning purposes.

Test Components and Price

  • Test Name: TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test
  • Components: NGS Technology
  • Price: 4400.0 AED

Sample Condition

The sample required for this test can be either blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

The report for this test will be delivered within 3 to 4 weeks.

Test Type and Doctor

This test falls under the category of Ear Nose Throat Disorders and will be conducted by an ENT Doctor.

Test Department

This test is conducted by our Genetics department.

Pre-Test Information

Prior to undergoing the GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB6.

This information will help in obtaining a comprehensive understanding of the patient’s genetic background and aid in accurate diagnosis.

At DNA Labs UAE, we strive to provide the highest quality genetic testing services. Our TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test can help individuals and families gain insights into their genetic makeup and make informed decisions regarding their health and well-being.

Test Name TBC1D24 Gene Deafness autosomal dominant type 65 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB6
Test Details

The TBC1D24 gene is associated with a form of deafness known as autosomal dominant type 65 (DFNA65). This condition is inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the condition on to each of their children.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. In the context of DFNA65, an NGS genetic test would involve sequencing the TBC1D24 gene to identify any genetic variants or mutations that may be responsible for the condition.

By identifying the specific genetic cause of DFNA65, NGS testing can help with accurate diagnosis, provide information on the inheritance pattern, and guide appropriate management and treatment options. It can also be useful for genetic counseling and family planning purposes.